Skip to main content
Peter Forsberg, MD, Oncology, Denver, CO

PeterForsbergMD

Oncology Denver, CO

Physician

Overview of Dr. Forsberg

Peter Forsberg, MD, is a fellowship-trained, board-certified hematologist/oncologist who has taken a clinical and research focus on the treatment of plasma cell disorders including multiple myeloma, amyloidosis and less common conditions such as Waldenstrom’s Macroglobulinemia. Known for providing high quality, cutting-edge care, Dr. Forsberg is regarded not only as an expert in the field, but also as an expert in building relationships with his patients through empathy, compassion and open communication.

Dr. Forsberg grew up in Littleton, CO, but left the state to complete his undergraduate studies at Washington University in St. Louis, MO. He returned to Colorado for medical school, completing his Doctor of Medicine degree at the University of Colorado School of Medicine. He then diversified his medical training with residency at the Weill-Cornell Medical College/New York-Presbyterian Hospital and served as chief medical resident at Memorial Sloan Kettering Cancer Center before returning to Cornell for fellowship training in hematology and medical oncology. He returned to Colorado once more in 2016 with a passion to bring his home state the highest quality, cutting-edge medical care at a caliber as high as anywhere in the nation.

Today, Dr. Forsberg has established trusted clinical practice while maintaining continuing research so he can bring his patients the most innovative, advanced treatments available. He serves as principle investigator on various clinical trials and has published and presented his work at the national and international level. In clinical practice, Dr. Forsberg believes in collaborative care. First, partnering with his patients— explaining diagnoses, presenting treatment options, and walking alongside them throughout their journeys. Secondly, partnering with his colleagues in the practice and throughout the system of care to create multidisciplinary plans of care that meet the unique needs of each patient.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2013 - 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 2009

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2016 - 2025
  • WY State Medical License
    WY State Medical License 2021 - 2025
  • CA State Medical License
    CA State Medical License 1964 - 2017
  • NY State Medical License
    NY State Medical License 2012 - 2017
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Broad Efficacy of the Translation Inhibitor Omacetaxine in Relapsed/Refractory Multiple Myeloma Samples
    Peter A Forsberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019